Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China

Xue-qing Liu,Shan Xue,Jia-bo Xu,Heng Ge,Qing Mao,Xin-hui Xu,Han-dong Jiang
DOI: https://doi.org/10.1038/s41401-021-00627-2
IF: 7.169
2021-03-19
Acta Pharmacologica Sinica
Abstract:Coronavirus disease 2019 (COVID-19) broke out in December 2019. Due its high morbility and mortality, it is necessary to summarize the clinical characteristics of COVID-19 patients to provide more theoretical basis for future treatment. In the current study, we conducted a retrospective analysis of the clinical characteristics of COVID-19 patients and explored the risk factors for the severity of illness. A total of 101 COVID-19 patients hospitalized in Leishenshan Hospital (Wuhan, China) was classified into three sub-types: moderate (<i>n</i> = 47), severe (<i>n</i> = 36), and critical (<i>n</i> = 18); their clinical data were collected from the Electronic Medical Record. We showed that among the 101 COVID-19 patients, the median age was 62 years (IQR 51–74); 50 (49.5%) patients were accompanied by hypertension, while 25 (24.8%) and 22 (21.8%) patients suffered from diabetes and heart diseases, respectively, with complications. All patients were from Wuhan who had a definite history of exposure to the epidemic area. Multivariate logistic regression analysis revealed that older age, diabetes, chronic liver disease, percentage of neutrophils (N%) &gt; 75%, CRP &gt; 4 mg/L, D-dimer &gt; 0.55 mg/L, IL-2R &gt; 710 U/mL, IL-8 &gt; 62 pg/mL, and IL-10 &gt; 9.1 pg/mL were independent variables associated with severe COVID-19. In conclusion, we have identified the independent risk factors for the severity of COVID-19 pneumonia, including older age, diabetes, chronic liver disease, higher levels of N%, CRP, D-dimer, IL-2R, IL-8, and IL-10, providing evidence for more accurate risk prediction.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?